The "Synthetic Data" Milestone: How 2026 is Solving the Oncology Privacy Crisis
By mid-2026, the industry has officially entered the era of "Generative Patient Simulation." This year, the focus is on the record-breaking success of Synthetic Data Vaults that allow pharmaceutical companies to train AI models on millions of "virtual patients" without ever touching real medical records. This innovation is a primary driver for the market, as the AI in Oncology Market has...
0 Reacties 0 aandelen 75 Views 0 voorbeeld
Sponsor